References

  1. Gallinat A. An impedance-controlled system for endometrial ablation: Five-year follow up on 107 patients. J Reprod Med. 2007; 52:467-472
  2. Cooper J, Gimpelson R, Laberge P et al. A randomized, multicenter trial of safety and efficacy of the Novasure System in the treatment of menorrhagia. J Am Assoc Gynecol Laparosc. 2002;9:418-428
  3. NovaSure Instructions for Use
  4. Kleijn JH, Engels R, Bourdrez P, Mol BW, Bongers MY. Five-year follow up of a randomised controlled trial comparing NovaSure and ThermaChoice endometrial ablation. BJOG 2008;115:193–8.
  5. El Nasher SA, Hopkins MR, Creedon DJ, et al; Prediction of Treatment Outcomes After Global Endometrial Ablation. Obstet Gynecol. 2009; 113(1)97-106
  6. Penninx, Josien PM, Mol BW, Engels R et al. Bipolar Radiofrwquency Endometrial Ablation Compared with Hydrothermablation for Dysfunctional Uterine Bleeding: A Randomized Controlled Trial. Obstet Gynecol. 2010; 116(4):819-826
  7. Bertrand J., J Minim Invasive Gynecol. 2005; 12(5): S14
  8. Use of the NovaSure Impedance Controlled Endometrial Ablation System in patients with intracavitary disease: 12-month follow-up results of a prospective, single-arm clinical study, J Minim Invasive Gynecol. 2006; 13: 476-471
  9. Use of the NovaSure Impedance Controlled Endometrial Ablation System in patients with intracavitary disease: 12-month follow-up results of a prospective, single-arm clinical study. J Reprod Med. 2007; 52:467-472
  10. Hologic 2009 Data on File.
  11. Hologic 2010 Data on File.
  12. A Safe and Effective Endometrial Sounding Device: SureSound; Adelstein D. Wareham, Mass; JMIG (2007) 14, November/December Supplement, S298.
  13. American College of Surgeons. Guidelines for Office-based Surgery (Adopted December 18, 2003).
  14. American Society of Anesthesiologists. Guidelines for Office-based Anesthesia (Approved by the ASA House of Delegates on October 13, 1999, and last affirmed on October 27, 2004).
  15. eMedicine, Toxicity, Local Anesthetics. Available at http://emedicine.medscape.com/article/819628-overview.
  16. Endometrial Ablation. ACOG Practice Bulletin No. 81. American College of Obstetricians and Gynecologists. Obstet Gynecol 2007; 109: 1233-1248.
  17. Istre O, et al. Treatment of menorrhagia with levonorgestrel intrauterine system versus endometrial resection. Fertil Steril. 2001; 76:304-309.
  18. Hurskainen R, et al. Clinical outcomes and costs with the levonorgestrel releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up. JAMA. 2004; 291:1456-1463.
  19. Mirena [page insert]. Wayne, NJ: Bayer HealthCare Pharmaceuticals Inc.; 2007.
  20. Backman T, Huhtala S, Blom T, Luoto R, Rauramo I, Koskenvuo M. Length of use and symptoms associated with premature removal of levonorgestrel intrauterine system: a nation-wide study of 17,360 users. BJOG 2000; 107:335-9.
  21. Cooper KG, et al. A randomised comparison of medical and hysteroscopic management in women consulting a gynaecologist for treatment of heavy menstrual loss. Br J Obstet Gynaecol. 1997; 104:1360-1366.
  22. Singh RH, et al. Hormonal management of abnormal uterine bleeding. Clin Obstet Gynecol. 2005; 48:337-352.
  23. Decherney AH, et al. Current Obstetric & Gynecologic Diagnosis & Treatment, ninth edition. New York, NY: McGraw-Hill Medical; 2003.
  24. Siddle N, et al. The effect of hysterectomy on the age at ovarian failure: identification of a subgroup of women with premature loss of ovarian function and literature review. Fertil Steril. 1987; 47:94-100.
  25. Thermachoice III. Instructions for Use. Ethicon, Inc., 2008.
  26. HydroThermAblator System. Instructions for Use. Boston Scientific Corporation, 2005.
  27. Her Option. Instructions for Use. American Medical Systems, Inc., 2006.
  28. *The average treatment time is 90 seconds, and the entire NovaSure procedure typically takes less than 5 minutes to complete.